Arnica Performance Gel
NDC Package 41391-121-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Arnica Performance Gel is a . Marketed by Myo-breathe,llc, this product is identified by NDC 41391-121.

Identification & Billing

NDC Package Code
41391-121-20
Package Description
89 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
41391-121
11-Digit Billing Format
41391012120

Clinical Specifications

Proprietary Name
Arnica Performance Gel
Dosage Form
-

Regulatory & Marketing

Labeler Name
Myo-breathe,llc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-25-2015
End Marketing Date
05-05-2019
Listing Expiration
05-05-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (41391-121). Click a package code to view its specific billing and regulatory data.

41391-121-21
59 mL in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 41391-121-20 identifies a specific commercial package of 89 ml in 1 bottle, with applicator of Arnica Performance Gel, labeled by Myo-breathe,llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Myo-breathe,llc on June 25, 2015. The current certification is valid through May 05, 2019.

How is this Myo-breathe,llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 41391012120. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
41391-121-20
11-Digit CMS (5-4-2)
41391-0121-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.